208 related articles for article (PubMed ID: 15813833)
1. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
Bergman MP; Klinkenberg-Knol EC; Faller G; Aar A; Lakhai W; Vandenbroucke-Grauls CM; Kuipers EJ; Appelmelk BJ
Aliment Pharmacol Ther; 2005 Apr; 21(8):977-83. PubMed ID: 15813833
[TBL] [Abstract][Full Text] [Related]
2. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
Lundell L; Havu N; Miettinen P; Myrvold HE; Wallin L; Julkunen R; Levander K; Hatlebakk JG; Liedman B; Lamm M; Malm A; Walan A;
Aliment Pharmacol Ther; 2006 Mar; 23(5):639-47. PubMed ID: 16480403
[TBL] [Abstract][Full Text] [Related]
3. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
Kuipers EJ; Lundell L; Klinkenberg-Knol EC; Havu N; Festen HP; Liedman B; Lamers CB; Jansen JB; Dalenback J; Snel P; Nelis GF; Meuwissen SG
N Engl J Med; 1996 Apr; 334(16):1018-22. PubMed ID: 8598839
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.
van Grieken NC; Meijer GA; Weiss MM; Bloemena E; Lindeman J; Baak JP; Meuwissen SG; Kuipers EJ
Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321
[TBL] [Abstract][Full Text] [Related]
5. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
[TBL] [Abstract][Full Text] [Related]
8. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
[TBL] [Abstract][Full Text] [Related]
9. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
10. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
12. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
[TBL] [Abstract][Full Text] [Related]
13. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
15. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.
Centanni M; Gargano L; Canettieri G; Viceconti N; Franchi A; Delle Fave G; Annibale B
N Engl J Med; 2006 Apr; 354(17):1787-95. PubMed ID: 16641395
[TBL] [Abstract][Full Text] [Related]
16. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria.
Iijima K; Sekine H; Koike T; Imatani A; Ohara S; Shimosegawa T
Aliment Pharmacol Ther; 2004 Jun; 19(11):1181-8. PubMed ID: 15153171
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
[TBL] [Abstract][Full Text] [Related]
20. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Moayyedi P; Wason C; Peacock R; Walan A; Bardhan K; Axon AT; Dixon MF
Helicobacter; 2000 Dec; 5(4):206-14. PubMed ID: 11179985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
